Metastatic Ureter Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241)	National Cancer Institute (NCI)	2014-12-11

Every clearance here is in the API, with alerts when new ones post.